Stifel and H.C. Wainwright Reiterate Stock Ratings for Multiple Companies

Stifel and H.C. Wainwright have reiterated their stock ratings for several companies, including Nlight, IDEXX Laboratories, Analog Devices, Veralto, Bitdeer, UroGen Pharma, Bright Minds, Seaport Therapeutics, Ultragenyx, and Zevra Therapeutics. These reiterations are based on various factors such as limited China exposure, data center strength, new deals, and contract agreements.